CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Pharmaxis Ltd - ADR Company Snapshot
Pharmaxis Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other companies in this sector in the United States: Aytu Bioscience Inc (2019 sales of $7.32 million of which 100% was Identifying, acquiring, and commercializ), Starpharma Holdings Limited ($1.94 million of which 100% was Dendritic), and Immutep Ltd ($4.31 million of which 93% was Cancer Immunotherapy).

Sales Analysis. Sales fell dramatically in 2019: During the year ended June of 2019, sales at Pharmaxis Ltd were $8.97 million. This is a sharp decrease of 77.0% versus 2018, when the company's sales were $38.93 million. The sales level in 2019 was fairly close to the level five years ago: in 2014, Pharmaxis Ltd had sales of $9.42 million.
   
   
 
  Stock Performance Chart for Pharmaxis Ltd - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (11/27/2019): 2.48
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
 
Pharmaxis Ltd - ADR Key Data:
  Ticker: PXSLY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 8,967,466
(Year Ending Jan 2020).
Employees: 107
  Currency: U.S. Dollars Market Cap: 65,193,545
  Fiscal Yr Ends: June Shares Outstanding: 26,287,720
  Share Type: Ordinary Closely Held Shares: 6,979,579
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.